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Streptococcus pneumoniae is a major cause of community acquired pneumonia and
septicaemia in humans. These diseases are frequently associated with thromboembolic
cardiovascular complications. Pneumococci induce the exocytosis of endothelial
Weibel-Palade Bodies and thereby actively stimulate the release of von Willebrand
factor (VWF), which is an essential glycoprotein of the vascular hemostasis. Both,
the pneumococcus induced pulmonary inflammation and the thromboembolytic
complications are characterized by a dysbalanced hemostasis including a marked
increase in VWF plasma concentrations. Here, we describe for the first time VWF
as a novel interaction partner of capsulated and non-encapsulated pneumococci.
Moreover, cell culture infection analyses with primary endothelial cells characterized
VWF as bridging molecule that mediates bacterial adherence to endothelial cells in a
heparin-sensitive manner. Due to the mechanoresponsive changes of the VWF protein
conformation and multimerization status, which occur in the blood stream, we used a
microfluidic pump system to generate shear flow-induced multimeric VWF strings on
endothelial cell surfaces and analyzed attachment of RFP-expressing pneumococci in
flow. By applying immunofluorescence visualization and additional electron microscopy,
we detected a frequent and enduring bacterial attachment to the VWF strings. Bacterial
attachment to the endothelium was confirmed in vivo using a zebrafish infection model,
which is described in many reports and acknowledged as suitable model to study
hemostasis mechanisms and protein interactions of coagulation factors. Notably, we
visualized the recruitment of zebrafish-derived VWF to the surface of pneumococci
circulating in the blood stream and detected a VWF-dependent formation of bacterial
aggregates within the vasculature of infected zebrafish larvae. Furthermore, we identified
the surface-exposed bacterial enolase as pneumococcal VWF binding protein, which
interacts with the VWF domain A1 and determined the binding kinetics by surface
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plasmon resonance. Subsequent epitope mapping using an enolase peptide array
indicates that the peptide 181YGAEIFHALKKILKS195 might serve as a possible core
sequence of the VWF interaction site. In conclusion, we describe a VWF-mediated
mechanism for pneumococcal anchoring within the bloodstream via surface-displayed
enolase, which promotes intravascular bacterial aggregation.
Keywords: endothelium, von Willebrand factor, enolase, Streptococcus pneumoniae, zebrafish
INTRODUCTION
In the course of systemic infection, Streptococcus pneumoniae
enters various tissue sites including bronchial airways, lung
alveoli and the blood stream (Bergmann and Hammerschmidt,
2006; Weiser et al., 2018). Thus, in young children,
immunocompromised and elderly humans, pneumococci
cause local infections but also severe systemic diseases, such
as community acquired pneumonia (CAP), meningitis and
septicemia (Cartwright, 2002). Cardiovascular diseases are
regularly reported complications of pneumococcal pneumonia
and septicemia. During the last decade, an increasing amount
of medical studies from the US and different regions in Europe
reported consistently that up to one third of patients suffer
from major adverse cardiac effects and vascular impairments
within months and even years after recovering from severe
pneumococcal infections (Musher et al., 2007; van Schie et al.,
2011; Corrales-Medina et al., 2015; Rae et al., 2016). Moreover,
pneumococci have been identified as causative agent for vascular
inflammation of the endothelial vessel wall including the aorta
(Sakai et al., 2000). In this respect, several formerly published
reports demonstrated adherence of S. pneumoniae to human
endothelial cells (EC’s), which is promoted by extracellular
matrix and plasma proteins, such as vitronectin (Bergmann
et al., 2009) and plasminogen (Bergmann et al., 2013). We
previously reported that the pneumococcus cell adherence to the
vascular lung endothelium immediately triggers the induction
of endothelial Weibel-Palade Body (WPB) exocytosis (Luttge
et al., 2012). Vascular homeostasis is regulated by WPB’s (Weibel
and Palade, 1964; Rondaij et al., 2004), which constitute specific
defense vesicles of human ECs and are mainly composed of von
Willebrand Factor (VWF), pro-angiogenic proteins, cytokines
and vasoactive substances (Ruggeri, 2001; Rondaij et al., 2006).
VWF circulates as a globular glycoprotein in the bloodstream
(Ruggeri, 2001) and also acts as plasma-carrier protein for
coagulation factor VIII (Ruggeri, 2001; Rondaij et al., 2006).
In addition to the circulating globular form of VWF, high
molecular weight (HMW) multimers can form strings of up
to several hundred micrometer in length on the surface of
stimulated EC’s or when attached to collagen exposed by vascular
injury in response to hydrodynamic forces generated by the
bloodstream. In this extended conformation, VWF plays a key
role in hemostasis by mediating adhesion of platelets to damaged
or inflamed vascular subendothelium (Tischer et al., 2017).
VWF is of high importance for a balanced hemostasis, since
quantitative or functional VWF deficiency causes vonWillebrand
disease, a common inherited bleeding disorder (Ruggeri, 2001).
Likewise, VWF concentration in the blood typically rises during
the course of acute coronary syndrome, and is an independent
predictor of adverse clinical outcome in these patients (Spiel et al.,
2008). Various lines of evidence indicate that VWF is not only a
marker but also actually an important effector in the pathogenesis
of myocardial infarction (Spiel et al., 2008). As a multi-domain
mosaic protein, VWF possesses several functionally important
domains, such as the central domains A1 and A3. These domains
are pivotal for platelet recruitment and are involved in anchoring
of VWF to collagen (Springer, 2014).
To understand the consequences of pneumococcus-
induced secretion of VWF for bacterial interaction with
the endothelium and possible implications in development
of cardiovascular disorders, we analyzed in detail the
interaction of pneumococci with plasma-derived VWF and
also with VWF strings on the surface of endothelial cells.
We identified and characterized the enolase as the bacterial
VWF binding protein and determined the role of VWF as
an adhesion cofactor promoting bacterial attachment to the
vascular endothelium. We monitored VWF-pneumococcus
colocalization and VWF-mediated bacterial aggregation in vivo
in zebrafish larvae. The zebrafish infection model is highly
suitable for our study, since bacterial infection of zebrafish is
commonly approved as an adequate in vivo model to study the
pathophysiology of various streptococcal infections including
pneumococcal diseases (Miller and Neely, 2004; Saralahti
et al., 2014; Saralahti and Rämet, 2015; Jim et al., 2016).
Moreover, it served as object of preference for hemostasis
and thrombosis studies due to high functional similarities
of coagulation cascades and additional high sequence based
similarities between zebrafish and human factors including VWF
(Weyand and Shavit, 2014).
Overall, our results underpin the function of VWF as
a coadhesin mediating attachment of pneumococci to the
endothelium in the blood flow. Furthermore, our in vivo data
visualize a VWF-mediated intravascular bacterial aggregation,
which suggests a pivotal role of VWF in reported long term effects
of pneumococcus pneumoniae and systemic infections.
MATERIALS AND METHODS
Bacterial Strains and Cultivation
VWF binding analyses were performed with seven different
pneumococcal strains including the laboratory strains: R6, R800,
TIGER4 (serotype 4), D39 (serotype 2), and serotype 35A,
and the clinical isolates of serotypes 23F and 12F. The strains
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differ in the amount of polysaccharide capsule as indicated in
results. Red fluorescent protein (RFP)-expressing serotype 35A
pneumococci were generated essentially as described in Kjos et al.
(2015). This serotype was also used in all cell culture infection
assays, microfluidic analyses and in vivo zebrafish infections. For
cell culture infection and binding analyses, pneumococci were
cultured on Columbia blood agar (Becton Dickinson) to mid-
log phase (OD600 of 0.35) at 37◦C and 5.0% CO2 or in Todd-
Hewitt broth (Becton Dickinson) supplemented with 1.0% yeast
extract (THY).
Proteins and Enzymes
Human VWF was purchased from Merck Chemicals; histamine
from Sigma Aldrich, Germany. The recombinant VWF domains
(A1, A2, and A3) were produced in HEK293 cells (Posch
et al., 2017). Pneumococcus-specific polyclonal antiserum was
generated in rabbit against heat inactivated serotype 35A and 2
bacteria (Pineda, Germany). IgG was purified using protein A/G
sepharose. Mouse anti-human VWF antibody (polyclonal IgG)
and FITC-conjugated VWF-specific antibody were purchased
from Abcam (ab8822), peroxidase-conjugated mouse anti-VWF
antibody from Hämochrom Diagnostika; Alexa Fluor 488-
conjugated goat anti-rabbit and goat anti-mouse IgG, Alexa
Fluor 568-conjugated goat anti-rabbit and goat anti-mouse
IgG were from Thermo Fisher Scientific (formerly Invitrogen),
paraformaldehyde (PFA) was purchased from EM Science and
mounting medium from Dako.
Bacterial Binding to Radiolabeled VWF
Human VWF was radiolabeled with 125iodine-isotope by
a standard chloramine T method and binding experiments
with [125I]-VWF were performed as described previously
(Bergmann et al., 2001). Briefly, 109 bacteria grown to
mid-log phase were incubated with 20 nCi of radiolabeled
VWF for 30min at RT. Pneumococci were sedimented by
centrifugation and after washing twice, pellet-bound radioactivity
representing bound VWF was measured in a gamma counter
(Packard). VWF binding was expressed as a percentage of total
added radioactivity. The labelling efficiency was calculated using
fetal calf serum and used to define the level of unspecific binding.
The shown binding data were normalized by subtraction of
this level.
In vitro Cell Culture Infection
Cell culture infection analyses were performed according to a
previously described standard procedure using serotype 35A
pneumococci grown to mid log phase (Bergmann et al., 2001).
This strain produces all essential traits of virulence and a
minor amount of capsule and is a commonly used model
strain for cell culture infection analyses. A detailed description
of cell cultivation and infection methodology is included in
Supplementary Material. In brief, after incubation of HUVEC
with different concentrations of VWF, the cells were incubated
with pneumococci for 3 h. Differential immunofluorescence
labeling enabled quantification of attached and internalized
bacteria as reported by Lüttge and colleges (Luttge et al., 2012).
For inhibition studies, either HUVEC or bacteria were incubated
with 30 IU heparin and with 3µg/ml VWF. As control, cells
were incubated with bacteria alone or with VWF-coated bacteria
without inhibitor substance. For control of inoculum, bacteria
were plated on THY- solid agar medium. Statistical significances
were analyzed by the ANOVA one –factorial test in case of the
infection analyses with different VWF concentrations and the
two-factorial variance analysis in case of the heparin-inhibition
analysis followed by a post-hoc two-tailed unpaired sample
test for detailed statistical comparison. P-values of <0.05 were
considered to be statistically significant.
Flow Cultivation and Infection
Flow cultivation was performed using the microfluidic system
of ibidi R© (Munich, Germany) and RFP-expressing serotype
35A pneumococci grown to mid log phase. In brief, primary
HUVEC were seeded on gelatin-coated 0.4mm µ-Slides (µ-
Slide I0.4 Luer, ibidi R©) and cultured in continuous flow of
5 dyne/cm2 for 30min followed by 10 dyne/cm2 for 48 h.
Prior to incubation for up to 3 h with 108 RFP-expressing
bacteria per ml, VWF secretion was stimulated with 1.0mM
histamine. For more detailed experimental procedure refer
to Supplementary Methods. Generation of VWF strings and
bacterial adherence was microscopically documented for up to
3 h using a FITC-conjugated, polyclonal anti-VWF antibody.
All experiments were performed in three independent assays,
each in triplicate and the data were expressed as mean
standard deviation.
Microscopic Illustrations
All microscopic images were taken with a Xenon fluorescence
device (30% power) of a SP8 confocal laser scanning microscope
(Leica) combined with the LasX-Software using a HC PL APO
CS2 63 x/1.40 oil objective and a resolution of 1,392× 1,040 pixel.
Brightness and contrast were adapted using Adobe Photoshop
CS5 (version 12.0.). For microscopic visualization of zebrafish
infection, a HC PLAPOCS2 20×/0.75 IMMobjective was used at
a resolution of 1,392× 1,040 pixel. Blood circulation in zebrafish
was monitored as video using 4 frames/min with a resolution of
1,392× 1,040 pixels.
Electron Microscopic Visualization
Samples were fixed in 5% formaldehyde and 2% glutaraldehyde
in cacodylate buffer, pH 6.9 (0.1M cacodylate, 0.01M CaCl2,
0.01M MgCl2, 0.09M sucrose) for 1 h on ice and washed
with TE-buffer, pH 7.0 (20mM Tris/HCl, 1.0mM EDTA)
before dehydrating in a graded series of acetone for 15min
at each step. Samples were then subjected to critical-point
drying with liquid CO2 (CPD 30, Bal-Tec, Liechtenstein). Dried
samples were covered with a gold film (SCD 500, Bal-Tec,
Lichtenstein) before examination in a field-emission scanning-
electron microscope Zeiss Merlin (Oberkochen, Germany)
using the Everhart Thornley SE detector and the SE inlens
detector at a 75:25 ratio with an acceleration voltage of
5 kV. Contrast and brightness were adjusted using Adobe
Photoshop CS5. Capsule expression of S. pneumoniae serotypes
shown in Figure 1 was visualized by transmission electron
microscopy on ultrathin sections after lysine-acetate-based
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FIGURE 1 | Streptococcus pneumoniae binds human plasma VWF. (A) Binding analyses with radioactive labeled VWF and seven S. pneumoniae strains: R6, R800
and the serotypes (st) 35A, 4 (TIGER4), 2 (D39), 23F and 12F. VWF binding was expressed as percentage of total radioactivity added. Amount of capsular
polysaccharides (CPS) was categorized according to the CPS-diameter determined by electron microscopic visualization: low encapsulation <0.03µm, middle
encapsulation in a range of 0.03–0.5µm and high encapsulation >0.5µm. Scale bars represent 0.5µm in the overview figures and 0.1µm in magnified sections. (B)
Immunofluorescence visualization of VWF binding to RFP-expressing pneumococci with FITC-conjugated VWF-specific antibodies after embedding of VWF-incubated
pneumococci in agarose. RFP-expressing bacteria appear in red at 540/590 nm and VWF-detection is visualized in green at 470/515 nm. VWF coated bacteria
appear in yellow in the merged channel. The insets visualize a representative fluorescence signal at 3-fold magnification. Antibody controls revealed no unspecific
VWF-signal detection on the surface of pneumococci (Ctrl). Scale bar represents 10µm. Fluorescence intensity determination visualizes the VWF-bacterial
colocalization within the region of interest (ROI 01).
formaldehyde-glutaraldehyde ruthenium red-osmium fixation
procedure (LRR fixation).
For immune labeling of VWF protein HUVEC cells, grown
on cover slips and infected with pneumococci, were incubated
with anti-VWF antibodies in a 1:75 dilution of the stock solutions
in PBS (mixture of polyclonal rabbit and monoclonal mouse
antibodies) for 1 h at 37◦C, washed with PBS and further
incubated with goat anti-mouse and Protein A coated gold-
nanoparticles with 15 nm in diameter in a 1:50 dilution of the
stock solutions. After incubation for 30min samples were washed
with PBS and TE buffer and critical-point dried. Dried samples
were sputter coated with carbon before examination in a Zeiss
Merlin (see above) applying the HESE2-detector and inlens SE-
detector in a 85:15 ratio with an acceleration voltage of 10 kV.
In vivo Colocalization Studies
Pneumococcus-VWF colocalization studies and detection of
bacterial aggregation were carried out by injecting RFP-
expressing serotype 35A bacteria in wild type larvae [WT
brass PBS 0545, 5 days post-fertilization (dpf)]. For some
experiments, the bacteria were pre-incubated with human
VWF as described above. After 2 h of cultivation in 30%
Danieau at RT, fixation of the larvae was performed by
incubation in 4% PFA in PBS over night at 4◦C. The
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formerly described immune fluorescence staining method was
applied with minor modifications (Luttge et al., 2012). The
detailed injection procedure and immune staining is described
in Supplementary Material. For microscopic visualization,
the stained larvae were embedded in 1.0% low melting
agarose. For each study, a minimum of 12 larvae were used
in two independent experiments. All procedures involving
zebrafish were carried out according to EU guidelines and
German legislation (EU Directive 2010_63, licence number AZ
325.1.53/56.1-TU-BS).
Dot Spot Overlay and Peptide Array
Enolase protein (rEno) of S. pneumoniae serotype 2 (ATCC
11733) was produced by the E. coli strain M15 and purified
as histidine-tagged fusion protein by imidazole-mediated
purification from NiNTA-columns (Macherey-Nagel) using
the clone pQE30eno. This clone was previously generated by
gene insertion into the pQE30 expression plasmid (Qiagen R©)
(Bergmann et al., 2001). For dot spot binding analyses,
rEno or VWF domains A1, A2, and A3 were immobilized
onto a nitrocellulose membrane (Whatman). After blocking
with 3% bovine serum albumin (Sigma Aldrich) for 1 h at
RT, the blot was incubated for 16 h with 2.0µg/ml VWF.
After washing with PBS supplemented with 0.05% Tween
20, detection of VWF-binding signals was performed by
incubation with monoclonal VWF-specific mouse antibodies
and alkaline peroxidase-labeled secondary antibodies. Signal
detection was visualized using BCIP/NBT liquid substrate
system Kit (Sigma Aldrich) according to the manufacturer’s
instructions. Dot spot analysis was repeated three times in
independent analyses. Detection of unspecific antibody binding
was analyzed by a second membrane without VWF incubation.
Control experiments are included in Supplementary Material.
Similarly, VWF domains A1, A2, and A3 were immobilized
in amount of 0.125 µg up to 1.0 µg and subjected to rEno-
overlay using 4.0µg/ml rEno. As control, 1.0 µg VWF and
1.0 µg rEno, respectively, was additionally immobilized and
detection of unspecific antibody signals was conducted with
a second membrane after identical probing but without
enolase incubation. Immunoblot analysis with anti-enolase
antiserum derived from rabbit was performed using alkaline
phosphatase (AP)-conjugated secondary antibody (Thermo
Fisher Scientific) and corresponding substrate solution (Sigma
Aldrich) as described above. After scanning, brightness and
contrast of the blots were adjusted using (Adobe Photoshop CS5,
version 12.0).
For peptide spot array, the enolase amino acid sequence
was divided into 141 overlapping peptides consisting of 15
amino acids each, with an offset of three amino acids. The
peptides were synthesized as an array of spots on an amino
pegylated cellulose membrane (AIMS Scientific Products GmbH,
Germany) (Beutling et al., 2008). For detection of peptides
mediating VWF-binding, membranes were treated as described
previously using 2.0µg/ml VWF followed by incubation with
an anti-VWF antibody and a peroxidase-labeled secondary
antibody. Binding signals were visualized by staining with 1.0
mg/ml 4-chloro-1-naphthol and 0.1% H2O2. After scanning,
contrast of the blots was adjusted using Adobe Photoshop CS5
without deleting any signal information.
The crystal structure of the octameric enolase of the serotype
2 pneumococcus (ATCC 11733, PDB entry 1W6T) was solved
previously at 2.0 Å and was used as matrix for visualization of
putative VWF binding sites (Ehinger et al., 2004). Molecular
visualization of the putative surface located VWF-binding
motives was performed with PyMOL.
Determination of Binding Kinetics
The association and dissociation reactions of human plasma
VWF to recombinant Enolase (rEno) were analyzed in
the BIAcore optical biosensor (BIAcore T200 system, GE
Healthcare, Munich, Germany) using CM5 sensor chips.
Covalent immobilization of rEnowas performed using a standard
amine coupling procedure as described previously (Bergmann
et al., 2003). Binding analyses were performed in phosphate
buffered saline (pH 7.4) containing 0.05%Tween 20 at 25◦C
using a flow rate of 10 µl/minute (min). Plasma VWF (Merck
Biochemicals) was used as analyte in concentrations of 0.625,
1.25, 2.5, 5.0, and 10.0µg/ml and VWF domains A1, A2, and A3
were used as analytes in concentrations of 0.0612, 0.125, 0.25,
0.5, and 1.0µg/ml. The affinity surface was regenerated with
2.0mM NaOH. Binding to enolase was examined in two (full
length VWF) or three (VWF A1 domain) independent kinetic
analyses. Calculated KD and Chi2-values were analyzed from
raw data using the 1:1 Langmuir binding model (mathematical
iteration) included in the Biacore T200 evaluation software
version 3.0. Representative fitting results and a table with
a detailed list of calculated binding parameter including Ka,
Kd, KD, RUmax, and Chi2-values is added to Figures S4A,B
and Table S4C.
RESULTS
Streptococcus pneumoniae Binds Human
Plasma-Derived VWF
Cellular infection analyses demonstrated that S. pneumoniae
adherence to endothelial cells induces the release of high
amounts of VWF from Weibel Palade Bodies into the cell
media (Luttge et al., 2012). To investigate if this highly adhesive
plasma protein might locally support bacterial cell adhesion in
blood vessels, we first performed VWF-pneumococci binding
studies. Recruitment of plasma-derived, radioactively labeled
125I-VWF to the surface of seven different S. pneumoniae
strains including clinical isolates with different amounts of
capsular polysaccharides (CPS) was determined (Figure 1A).
Grading of capsule thickness into low (<0.03µm), middle
(0.03–0.5µm) and high (>0.5µm) encapsulation was defined
by computation of capsule diameter according to electron
microscopic visualization. While all serotypes exhibited VWF-
interaction, the binding activity increased with decreasing
capsule diameter (Figure 1A). These data were confirmed by
immunofluorescent detection of VWF on the surface of RFP-
expressing S. pneumoniae serotype 35A, which is a widely
used model organism for interaction studies (yellow in overlay
Figure 1B, merge, ROI 01). In summary, radioactive binding
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analysis and immunofluorescence studies demonstrate that
various capsulated and non-capsulated S. pneumoniae strains and
serotypes are able to bind VWF.
VWF Mediates Bacterial Adherence to
Endothelial Cells
Since pneumococci can recruit plasmatic VWF, we further
investigated if this interaction might influence bacterial
attachment to the endothelium. We performed cell culture
infection studies with HUVEC and serotype 35A pneumococci,
which had been pre-incubated with VWF. This serotype is less
capsulated and is widely used as reliable model organism in
many cell culture infections (Bergmann et al., 2009; Luttge et al.,
2012). Serial immunofluorescent staining of non-permeabilized
and permeabilized cells was used to distinguish between surface-
attached and internalized bacteria, respectively, and revealed an
increase in VWF-mediated bacterial attachment depending on
the amount of endothelial-bound VWF (Figures 2A,C), whereas
VWF did not influence intracellular uptake of pneumococci
into HUVEC (Figures 2B,C, marked by white arrows). The
A1-domain of VWF exposes a heparin binding site (Rastegar-
Lari et al., 2002). Thus, to assess whether heparin competes
with VWF binding to HUVEC and in consequence abrogates
the VWF-mediated adherence mechanism, infections were also
performed in the presence of 30 IU heparin. Indeed, heparin
significantly reduced VWF-mediated pneumococcal adherence
(Figures 2D,F). Again, VWF-mediated bacterial internalization
was not substantially affected by heparin (Figure 2E). Pre-
incubation of bacteria with VWF rather doubled bacterial
attachment from 28 bacteria per cell to 44/cell (Figures 2G,I).
This increase in attachment was significantly inhibited by
heparin (Figures 2G,I). In accordance with data for HUVEC
pre-incubation with VWF, bacterial internalization rate remained
unchanged (Figures 2H,I).
In addition to the immuno fluorescence visualization,
Field Emission Scanning Electron microscopy (FESEM) of the
HUVEC surface after 2 h of pneumococcal infection impressively
visualizes several spots of bacterial attachment to long protein
strings (Figure 2J, colorized image and gray scale images).
Valentijn and coworkers already described these strings as HMW
VWF structures, which are secreted from characteristic secretory
pods (Valentijn et al., 2011) (Figure 2J, bottom panel with white
arrow). In addition, immuno-labeling identified those strings as
VWF protein containing structures (inserts i and ii in Figure 2J,
bound gold-nanoparticles are marked with arrow heads).
Pneumococci Bind VWF Strings Under
Shear Flow Conditions
VWF is a mechanosensitive protein, which alters its structural
conformation and its multimerization status upon shear stress
generated by the blood flow (Ruggeri, 2001). With the aim
to analyse pneumococcus attachment to multimerized VWF
strings, a microfluidic approach (ibidi R©) was established
(Bergmann and Steinert, 2015). This approach enabled the
simulation of the situation in the human vascular system,
in which VWF strings are generated on endothelial cells
under flow conditions. In order to visualize and to quantify
pneumococcus attachment to generated VWF strings on
endothelial cells, VWF-secretion of confluently grown HUVEC
was induced by histamine stimulation at a shear rate of 10
dyne/cm2 and RFP expressing serotype 35A pneumococci
grown to mid log phase were injected into the flow. The first
events of bacterial attachment to VWF strings were detected
after 30min post-injection of RFP-expressing pneumococci
to the histamine-stimulated HUVEC in flow (Figures 3A,B,
white arrows). On average, pneumococcus attachment was
monitored at one out of eight visualized VWF strings after
90min at constant unidirectional shear flow and was confirmed
by histogram overlay showing overlapping fluorescence
peaks for VWF and attached pneumococci (Figure 3B). The
bacteria remained attached to the VWF strings for at least
25min at constantly high shear rates. Absolutely no bacterial
attachment to VWF strings was detected in the presence of
heparin (Figure S7), which strongly suggested that heparin
binding sites are required for bacterial attachment to VWF
strings in flow. In addition to a recruitment of circulating
VWF to the bacterial surface, the microfluidic approach
confirmed a tight attachment of pneumococci to VWF strings
generated in flow.
Pneumococci Colocalize With VWF in
Danio rerio and Form Bacterial Aggregates
In order to confirm that VWF can trigger pneumococci
aggregation in the vasculature in vivo, the D. rerio vertebrate
model was chosen. This in vivo model provides a complete
blood environment whose hemostasis and thrombosis
mechanisms and factors share high similarity to the human
physiology especially in terms of coagulation and fibrinolysis
(Hanumanthaiah et al., 2002; Jagadeeswaran, 2005; Ghosh
et al., 2012; Weyand and Shavit, 2014), which renders this
model suitable to study the role of VWF-pneumococcus
interaction in hemostasis. After injection of RFP-expressing
serotype 35A pneumococci into the heart chamber of 5 days
old wildtype zebrafish, microscopic visualization of histological
immunofluorescence staining detected VWF recruitment to
circulating diplococcoid pneumococci or short pneumococci
chains into various regions of the vasculature and nearby
tissue in the larvae (Figure 4A, larvae 1, 2, 3, white arrows).
Fluorescence intensity histograms confirmed the localization
of VWF-coated pneumococci in intersegmental blood vessels
passing through the trunk muscles (larva no. 1), in close
proximity to the heart (larva no. 2) and within the gill arches that
sustain the vasculature (larva no. 3). The colocalization of VWF
with pneumococci circulating in zebrafish larvae demonstrates
that the recruitment of VWF to the pneumococcal surface takes
place in vivo.
To confirm the visualization of bacterial circulation within
the fish vasculature, RFP-expressing pneumococci were injected
into the heart chamber of larvae of a zebrafish transgenic strain
TgCflk1:mcherryCAAX expressing a membrane targeted red
fluorescent protein in endothelial cells. Representative images of
the vasculature of three larvae (Figure S3A) in addition to videos
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FIGURE 2 | VWF mediates pneumococcal adherence to endothelial cells. Microscopic determination of VWF-mediated bacterial adherence to subconfluently grown
endothelial cells (HUVEC) and internalization after immunofluorescence staining with pneumococcus-specific rabbit antibodies followed by Alexa 488 and Alexa
568-conjugated secondary antibodies. HUVEC were pre-incubated with 0.1, 1.0, and 10.0µg/ml VWF. Three independent assays were conducted in triplicate. After
visual control of cell morphology and staining efficiency, number of yellow fluorescent attached bacteria (A) and number of red fluorescent internalized bacteria (B)
were counted for a minimum of 50 endothelial cells in each sample. Representative images are shown in (C). White arrows indicate detection of internalized
pneumococci. Scale bar represents 10µm. Quantification of bacterial adherence (D) and internalization (E) in cell culture inhibition studies with 3.0µg/ml VWF in
presence of 30 IU heparin. Adherence and internalization were microscopically determined as described above (F). All data shown in Figure 2 represent mean values
± SEM; statistical significance was evaluated by unpaired Student’s t-test (*p < 0.05 was defined as significantly different). Scale bar represents 10µm. Effect of
heparin on extent of VWF-mediated bacterial attachment (G,I) and internalization (H,I) was further determined after VWF-pre-incubation of bacteria instead of HUVEC.
All data shown in Figure 2 represent mean values ± SEM; statistical significance was evaluated by unpaired Student’s t-test (*p < 0.05 was defined as significantly
different). Scale bar represents 10µm. (J) Electron microscopic visualization of pneumococcus attachment to protein strings on HUVEC. Samples were subjected to
field emission scanning electron microscopic visualization with a Zeiss Merlin FESEM, which illustrates pneumococcal attachment to long protein strings resembling
VWF-strings in length and size. Colors have been applied by Adobe Photoshop CS5 v12.0 for emphasizing structural differences. RFP-expressing pneumococci are
colorized in red, HMW VWF protein strings appear in green and the HUVEC cell background appears in dark blue. The white arrow in the lower left image points to a
diplococcus bound to a VWF protein string, which is released by a secretory pod on the cell surface. The two insets visualize a VWF-specific immune-gold staining of
a long, thin VWF-string (i) and of a short VWF string (ii). The gold-conjugated particle are marked with white arrow heads. The lower right picture shows a 5-fold
magnification of the region marked with a white square. Scale bars of the insets represent 0.2µm, the other scale bars are depicted in illustrations.
of the region depicted for larva no.3 are shown in Videos S1–S3.
These recordings reaffirm the localization of pneumococci along
the endothelium.
With the aim to visualize effects of pneumococcus-VWF-
interaction on vascular integrity, bacteria were injected into
the heart chamber of zebrafish larvae without VWF and after
pre-incubation of RFP-expressing pneumococci with human
VWF. Without VWF-pre-incubation of pneumococci, only
single diplococcoid bacteria were detected 5 h after zebrafish-
infection (Figure 4B, without VWF, merge, white arrows). Since
the VWF signal was visualized by green fluorescence after
immuno staining with VWF-specific antibodies, the yellow
appearance of pneumococci in the merged illustration indicates
the recruitment of zebrafish-derived VWF in green to the
surface of the red fluorescing bacteria (Figure 4B, without
VWF, merge, white arrows). As physiological reference and
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FIGURE 3 | Pneumococci bind to VWF strings generated in continuous flow. (A) HMW VWF fiber generation was microscopically quantified after exposing confluently
grown HUVEC to shear stress using a microfluidic device (ibidi®) at 10 dyne/cm2. FITC-conjugated VWF-specific antibodies detected HMW VWF strings. White
arrows point to red fluorescent pneumococci attached to long VWF strings. (B) Attachment of RFP-expressing pneumococci to green fluorescent VWF strings was
microscopically observed after 30min in constant flow (white arrows) and was confirmed by software-based evaluation of fluorescence intensities of the defined ROI.
Pictures were taken in real time using the fluorescence equipment of a confocal laser scanning microscope (SP8, Leica). Scale bar represents 10µm.
orientation, the tail region of the zebrafish larvae, which was used
for representative microscopic visualization of pneumococci
after infection, is marked with a red square (Figure 4Ba).
In addition, a fluorescence micrograph of this zebrafish
region shows the position of the red fluorescent endothelial
vasculature of a transgenic zebrafish (TgCflk1:mcherryCAAX,
Figure 4Bb).
After 5 h of larval infection with VWF-pre-incubated
pneumococci, VWF-containing bacterial aggregates of up to
10µm in diameter were detected by immune microscopy within
the vasculature of the larval tail region (Figures 4B,C with
VWF, merge, yellow arrows). The aggregates line the curved
shape of the main blood vessel and appear very often at the
bending of vascular branching sites, which display a non-laminal
blood flow and a slightly reduced flow speed. Besides the tail
region, bacterial aggregates were found to be distributed in a
widespread manner and could be visualized for example in
the vasculature near the heart or close to the eye (Figure 4C).
A histogram of fluorescence signal overlaps in the aggregates
is added in Figure S3B. This immune staining supports the
idea that VWF recruitment to the pneumococcal surface
contributes to bacterial aggregation within the vasculature
in vivo.
VWF Binds to the Non-classical Surface
Protein Enolase
After having shown that pneumococci bind to VWF, we strived
to identify the interacting bacterial surface protein. In previous
studies, we described the major glycolytic enzyme enolase of
S. pneumoniae as surface-located binding protein for another
plasma glycoprotein, namely the host-derived fibrinolysis factor
plasminogen (Bergmann et al., 2001, 2003, 2005). Since VWF
is also a plasmatic glycoprotein, we investigated if enolase
might also exhibit VWF-binding activity. Dot blot screening
analyses indeed revealed binding of purified His6-tagged
pneumococcal enolase (rEno) to VWF in a dose-dependent
manner (Figure 5A).
Binding of VWF to immobilized enolase protein was
also further biochemically characterized by surface plasmon
resonance analysis, which provides the determination of kinetic
parameters of the VWF-enolase interaction (SPR, Figures 5B,
S4A and Table S4C). At flow rates of 10 µl per minute different
amounts of plasma-derived, non-labeled VWF bound to enolase
in a dose-dependent manner. Evaluation of binding data using
a 1:1 Langmuir model revealed an average dissociation constant
(KD) of 5.36 × 10−9 M (Figure 5B), thereby indicating a
strong interaction.
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FIGURE 4 | Colocalization of pneumococci with VWF in vascular system of Danio rerio. (A) Colocalization of red fluorescent pneumococci with zebrafish-derived VWF
was microscopically visualized after fixation, embedding, and staining of wild type larvae with VWF-specific rabbit FITC-conjugated antibodies and pneumococcus
specific rabbit antibodies followed by goat Alexa 568-conjugated antibodies. Visualization of three representative larvae (no. 1, 2, and 3) is shown after digital zoom in
magnification of the region marked by white and subsequently by black squares. All larvae are displayed from ventral side. The white square encircles intersegmental
vessels of the trunk muscles in larva 1, the heart vasculature of larva no. 2 and the vessels of the gill arches of larva no. 3. White arrows of R1–R5 point to VWF
colocalization with single diplococci or short pneumococcus chains appearing as yellow overlay. Colocalizations within selected regions of interest (zoom in ROI) are
confirmed by corresponding overlay histograms. Scale bars represent 10µm. (B) Visualization of RFP-expressing serotype 35A pneumococci in zebrafish larvae
without and after pre-incubation of pneumococci with human VWF prior to injection of 600 cfu into the heart chamber. The red square in the zebrafish illustration
depicts the region of the zebrafish tail, which is focused for visualization after immunostaining. Using a transgenic zebrafish larva, which expresses red-fluorescing
endothelium (FLK1:mCherryCAAX), the position of the main blood vessel and its branching circular microvasculature within the tail region are visualized in b. After 5 h
of infection with non-VWF-pre-incubated RFP-expressing pneumococci (without VWF), only single diplococci are detected within the intersegmental blood vessels of
the tail region of cross linked larvae after immune staining of VWF (green) (without VWF, merge, white arrows). The yellow appearance in the merged illustration points
to the recruitment of zebrafish-derived VWF to the surface of the bacteria. After 5 h of infection with VWF pre-incubated pneumococci, several bacterial aggregates
were detected after immunostaining of VWF in green and bacteria in red as yellow clumps of up to 10µm in size in the vasculature of the zebrafish tail (+VWF, merge
and BF + merge, yellow arrows). (C) A further representative example of VWF-mediated pneumococcal aggregate formation with the vasculature of an infected
zebrafish larva. A zoom in into the zebrafish region in close proximity to the larval heart (white square) visualizes a cluster of pneumococci (+VWF, merge, red arrows).
A histogram of fluorescence signal overlaps in the aggregates is added in Figure S3B. Scale bars represent 10µm.
VWF Binds to a Putative Binding Groove of
Pneumococcal Enolase
As surface displayed moonlighting molecule, the enolase elicits
a couple of adhesive functions which are mediated via different
binding domains on the molecule surface (Fulde and Bergmann,
2017). With the aim to identify putative VWF-binding domains
of the pneumococcal enolase, the whole enolase amino acid
(aa) sequence was scanned by peptide spot analysis with
15mer overlapping peptides (Figure 6A). The VWF overlay
assay revealed positive and VWF-specific signals for 21 peptides
comprising seven putative protein binding sites (Figure 6B).
Only marginal unspecific background binding of the applied
antibodies is detected without VWF incubation (Figure S1B).
Based on a densitometric quantification of spot intensity, only
the peptide regions 1, 2, 3, 6, and 7 mediated strong VWF
interaction signals (Figure 6C). The structural localization of
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FIGURE 5 | Enolase of S. pneumoniae binds VWF derived from human
plasma with high affinity. (A) VWF dot spot overlay of recombinant enolase
protein (rEno) of S. pneumoniae and VWF which were immobilized by dot
spotting onto nitrocellulose in indicated amounts (VWF was used as positive
control). Dose-dependent VWF-binding signals to rEno were detected by
VWF-specific antibodies and visualization by chemiluminescence. Antibody
controls are shown in Figure S1A. (B) Binding kinetics of rEno and
plasma-derived VWF were determined by SPR using rEno as immobilized
ligand on CM5 Biacore Chips and plasma VWF as analyte in concentrations of
0.625–10µg/ml. Data evaluation was determined in two independent analyses
using a 1:1 Langmuir model and revealed an average dissociation constant KD
of 5.36 × 10−9 M at a Chi2-value of 0.665. Kinetic determination was
performed with a BIACORE®T200 (GE Healthcare) at a flowrate of 10 µl per
min. A representative sensorgram is shown.
all seven regions within the three-dimensional enolase molecule
structure formerly solved by Ehinger and colleagues (Ehinger
et al., 2004) revealed that six of the seven putative binding
regions are mostly hidden within the molecule. Only the protein
region no.3 (aa 189–219, Figure 6D; marked in orange) with the
strongest VWF-binding core peptide 181YGAEIFHALKKILKS195
(Figure 6D; marked in red), is located on the molecule’s surface
at the interface of two adjacent enolase monomers (Figure 6Da),
thereby possibly forming a long putative VWF-binding pocket
on each of the four enolase dimers (Figure 6Db). The grooved
shape of the binding pocket formed by the VWF-interacting
peptides colored in red and orange is also depicted in the top
view (Figure 6Db and Figure S5). Results of the peptide array in
combination with structural localization provide a first hint of a
putative VWF-binding site.
The A1 Domain of VWF Serves as Enolase
Binding Site
Depending on the location of the binding site, the enolase might
interfere with crucial VWF functions. The VWF A domains are
involved in binding of a variety of protein partners, thereby
mediating crucial functions of VWF in hemostasis (Springer,
2014). To identify the VWF binding domain for the enolase we
first performed a dot spot overlay using purified single VWF
A domains. Densitometric analysis indicated that the strongest
signal for enolase binding was detected for A1 (Figures 7A,B).
A3 gave only a marginal signal while A2 exhibited no binding
(Figures 7A,B). For antibody negative controls, the positive
control with full-length VWF, and the SDS-PAGE analysis of A
domain peptides please refer to Figures S2A,B. Evaluation of
kinetic parameters by SPR studies confirmed the high affinity
interaction of immobilized enolase with the VWF A1 domain
with an average KD of up to 2.08 × 10−10 M in the 1:1
Langmuir model (Figures 7C, S4B and Table S4C). In contrast,
no specific interaction was detected to VWFA2- and A3 domains
(Figure 7C). This data identified the A1 domain of VWF as
binding site of pneumococcus enolase.
DISCUSSION
This report for the first time describes both, binding of
S. pneumoniae to globular as well as shear-elongated VWF
and that this interaction promotes bacterial adherence to
endothelial cells in vitro and in vivo. Previously, a direct
VWF binding has only been reported for two Staphylococcus
species, S. aureus, and S. lugdunensis (Herrmann et al., 1997;
Nilsson et al., 2004). Similar to encapsulated Staphylococcus
strains, serotype-dependent differences in capsule expression of
pneumococci are affecting the VWF binding activity. Of note,
all tested pneumococcus serotypes bound VWF. S. pneumoniae
is a pathobiont of the human respiratory surfaces and in
addition to a symptomless colonization, pneumococci cause local
infections and life threatening diseases, such as pneumonia,
meningitis and septicemia (Cartwright, 2002; Weiser et al.,
2018). In order to facilitate the colonization of mucosal
surfaces, pneumococci produce a broad repertoire of cell
surface proteins which either mediate direct adherence to
eukaryotic cell surface receptors or subvert adhesive matrix
molecules and plasma-proteins, such as vitronectin, fibronectin,
and plasminogen as molecular bridges for bacterial adherence
(Bergmann and Hammerschmidt, 2006; Voss et al., 2012;
Weiser et al., 2018). Our cell culture infection analyses
with pneumococci showed a dose-dependent VWF-mediated
adherence to HUVECs, which prompted us to designate VWF
as a novel adhesion cofactor for pneumococcal attachment to
the endothelium.
Pneumococci also adhere to endothelial cell surface anchored
VWF strings in shear flow of 10 dyne/cm2. Of note,
pneumococcal attachment to VWF strings is a reproducibly
monitored event in our assays, which is also characterized
by substantial stability. Moreover, S. pneumoniae is the most
frequent cause of community acquired pneumonia (CAP), which
can progress to a septicemia due to systemic dissemination
(Jain et al., 2015). The strong and shear flow resistant
attachment of pneumococci to VWF strings generated on
activated endothelium might contribute to the severe infection
outcome, since the attached pathogen might be protected against
mechanical clearance of the blood flow. In this respect, the
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FIGURE 6 | Identification of a putative VWF binding site on the pneumococcal enolase. (A) VWF overlay of enolase peptide spot array, representing the whole enolase
amino acid sequence, identified up to seven regions displaying VWF-binding activity. Antibody controls are shown in Figure S1B. (B) Table of peptide sequences of all
peptide spots showing VWF-binding activity. The strongest VWF-binding signal shows peptide “181YGAEIFHALKKILKS195” of region no. 3 (marked in red). (C)
Densitometric quantification of signal intensity. The seven regions with positive signals are numbered and marked with squares. Peptide region Nr. 3 is located on the
enolase molecule surface and the core peptide is marked in red and the adjacent peptide spots are marked in orange. (D) Localization of the putative VWF-binding
pocket within the octameric enolase molecule depicts alternating enolase monomers colored in yellow and green; the VWF-binding site is highlighted within one of the
four dimers colored in gray (a). The whole VWF-binding peptide region no. 3 representing aa 181–195 is marked in orange and the core peptide composed of aa
181–195 is marked in red. Top view of the VWF binding groove of a dimer is shown in (b). Additional views are added in Figure S5. Structure visualization was
calculated using PyMOL.
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FIGURE 7 | Identification of VWF domains interacting with S. pneumoniae enolase. (A) Enolase protein overlay of VWF domains A1, A2, and A3 after immobilization of
these domains by protein dot spotting on nitrocellulose at indicated amounts (1.0, 0.5, 0.25, and 0.125 µg). 1.0 µg VWF protein was immobilized as positive binding
control and 1.0 µg rEno as antibody control. Protein overlay was performed with 1.0µg/ml rEno and enolase-specific antibodies. Antibody overlay controls are shown
in Figure S2A. (B) Densitometric analysis was performed with ImageJ version 1.49v after subtraction of antibody background. Mean density values are displayed as
percent in relation to maximum density. (C) SPR analysis of immobilized rEno on Biacore CM5 sensor chips confirmed binding of VWF domain A1 to immobilized
rEno, whereas no specific binding of VWF domains A2 and A3 to immobilized enolase was detected. Kinetic analyses revealed an average KD of 2.08 × 10
−10 M
with a Chi2-value of 2.4 for the interaction of rENo with VWF domain A1 using a Langmuir 1:1 model. Three independent binding analyses were performed with a
BIACORE®T200 (GE Healthcare) at a flowrate of 10 µl/min after immobilization of 1,700 RU rEno. A representative sensorgram is shown for VWF domain A1. A
coomassie stain confirming protein integrity of the A domains is added in Figure S2B.
pneumococcus-VWF interaction may directly contribute to the
pathogenesis of severe pneumococcus infections.
We further identified the pneumococcal enolase as a novel
VWF binding protein and it is the first that has been described
for pneumococci. Only three bacterial VWF-binding proteins
have been identified so far; in 2000 (Hartleib et al., 2000)
and in 2002 (Bjerketorp et al., 2002), S. aureus protein A
(SPA) and protein vWbp. The third was found by Nilsson and
coworker and named VWF-binding protein (vWbl), which is
expressed by S. lugdunensis strains (Nilsson et al., 2004). In
contrast to the shear stress-dependent VWF interaction with
SPA (Pappelbaum et al., 2013), enolase also interacts with
soluble plasma VWF. Biochemical characterization of VWF
binding kinetics has so far only been reported for SPA by
SPR studies demonstrating a KD of 1.49 × 10−8 mol (Hartleib
et al., 2000). We determined KD values of similar order
of magnitude by SPR (5.36 × 10−9 mol), pointing to the
high physiological relevance of VWF-binding to pneumococcal
enolase. The enolase is a major glycolytic enzyme, which
converts 2-phosphoglyceric acid into phosphoenolpyruvate
and immune electron microscopic visualization confirmed
that it is ubiquitously expressed and surface exposed by all
S. pneumoniae strains irrespective of serotype and capsule
expression (Bergmann et al., 2001). Genetic deletion of the
enolase gene is lethal due to the lack of any compensatory energy
pathways; therefore, knock-out experiments are impossible.
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Moreover, the hydrolytic activity of the enolase depends on
an accurately folded octameric structure which renders the
protein function highly sensitive toward site-specificmutagenesis
resulting in single point mutations. Since the putative VWF
binding site is located within a structurally important interdimer
region, experimental methods for binding site reaffirmation
are limited.
In former studies, we characterized the enolase as a
surface displayed plasminogen binding protein, which promotes
bacteria-driven fibrinolysis (Bergmann et al., 2001, 2003,
2005; Fulde et al., 2013). The plasminogen binding site
(248FYDKERKVY256) is localized at a surface exposed loop in
spatial distance to the identified VWF binding pockets formed
by the sequence 181YGAEIFHALKKILKS195, indicating that the
enolase might be able to interact with both plasma proteins.
The consequences of VWF binding for plasminogen-mediated
fibrinolytic activity of pneumococci and vice versa is a matter of
further in depth studies.
Interestingly, another group revealed that virulence-
associated functions of streptococcal and staphylococcal
enolases, such as plasminogen binding, are also exhibited by
enolases from commensal lactobacilli (Antikainen et al., 2007).
In line with this report, we also described an interaction of
the bifidobacterial enolase with plasminogen in former studies
(Candela et al., 2009). Similar to lactobacilli, bifidobacteria are
considered as non-pathogenic commensals and colonize the
human intestine. Despite the fact that the catalytic domain of
enolases and their function as plasminogen binding protein
are highly conserved among different bacterial species, an
amino acid sequence comparison of putative VWF-binding sites
between enolases from S. pneumoniae, S. aureus, Lactobacillus
plantarum, E. coli, and Bifidobacterium lactis revealed significant
differences between pathogenic species and commensals (refer
to Table S6). It has been suggested that the plasminogen
binding activity of Bifidobacteria might improve their long-
term settlement within the mucus layer of the gut enterocytes
(Candela et al., 2009). Similar to the subversion of plasminogen
for bacterial attachment to host tissues, the VWF-pneumococcus
interaction promotes the endothelial cell adherence and provides
a first spot of settlement for circulating cocci in the blood stream.
This might facilitate the activation of further infection steps,
which are depending on the specific virulence equipment of each
bacterial species. In this respect, the specific sequence differences
in VWF-binding sites of bacterial enolases might indicate that the
VWF binding via enolase contributes to the infection process and
characterizes the enolase-VWF interaction as new virulence trait
of pneumococci.
With the aim to obtain information about a possible
functional interference of the enolase-VWF interaction with
crucial VWF activities, we analyzed the VWF binding sites, which
are targeted by enolase. As VWF interaction site for enolase
of S. pneumoniae, we identified the VWF A1 domain. It has
been demonstrated that the shear forces within the blood flow
stretch the VWF molecule, thus exposing functional binding
sites of the A1 for platelets (Springer, 2014; Lof et al., 2017).
The VWF A1 domain provides binding sites not only for the
platelet glycoprotein Ib and heparin, but also for collagen types
I, IV, and VI and to some extent also type III (Rastegar-
Lari et al., 2002; Schneider et al., 2007; Flood et al., 2015).
In accordance to our data, the A1 domain was identified as
binding site for S. aureus, although solely at high shear flow
(Pappelbaum et al., 2013). Our binding studies clearly confirmed
that a molecular stretching of VWF is not necessary to enable
an interaction with enolase or alive pneumococci. This is a
remarkable result, since the multidomain glycoprotein VWF
circulates as a globular molecule in the human vasculature
at a concentration range between 6.0 and 14.0µg/ml (Spiel
et al., 2008). Pathogenesis of bacterial infections, such as the
infective endocarditis involves the enhanced secretion of VWF,
which elicits crucial functions in platelet adhesion and thrombus
formation at endothelial damage sites (Springer, 2014). VWF
is released in high amounts during stress, inflammation, sepsis,
and cardiovascular diseases and is also regarded as an indicator
of vascular dysfunction (Spiel et al., 2008; Springer, 2014).
As demonstrated by us in previous studies, luminal VWF
secretion from WPB of HUVEC and human lung EC’s is
significantly increased in response to pneumococcal adherence
(Luttge et al., 2012). This increase in VWF secretion might
result in higher concentrations of VWF in plasma, which in
fact is also associated with an increased risk of myocardial
infarction, ischemic stroke, and arterial thrombosis (Sakai et al.,
2000; Gragnano et al., 2017). Moreover, Kawecki and colleagues
published a comprehensive review about case reports and animal
studies demonstrating that inflammation additionally leads to
local inhibition of ADAMTS13-mediated VWF cleavage and
to a dysbalanced VWF:ADAMTS13 ratio, thereby promoting
thrombosis and disseminated intravascular coagulation (Spiel
et al., 2008; Kawecki et al., 2017). All these former reports strongly
imply a direct contribution between the pneumococcus-VWF
interaction and the cardiovascular pathophysiology associated
with severe systemic infections. In regard of these coherences,
we wanted to analyse the interaction of pneumococci with VWF
in a complex living system and performed infection analyses
with Danio rerio larvae as in vivo model of a complete blood
environment. It should be noted that the zebrafish endothelium
shares high morphologic and functional similarity to the human
endothelial tissue (Kamei et al., 2006) and several publications
describe the presence of intrinsically and extrinsically triggered
coagulation pathways in D. rerio (Hanumanthaiah et al., 2002;
Weyand and Shavit, 2014). The factors involved in hemostasis,
such as VWF share identical functionalities with human clotting
factors and also a high degree of protein sequence similarities
(Hanumanthaiah et al., 2002; Weyand and Shavit, 2014). This
gives solid reason for the extended use of this model for studying
the interaction of hemostatic proteins and its suitability for
addressing our scientific questions. Additionally, during the
last decade, many reports describe infection studies of larval
and adult zebrafish with different streptococcal species and
present the zebrafish as valuable in vivo model for streptococcal
and pneumococcal virulence (Phelps et al., 2009; Patterson
et al., 2012; Rounioja et al., 2012; Borst et al., 2013; Saralahti
et al., 2014; Kim et al., 2015; Saralahti and Rämet, 2015;
Jim et al., 2016; Membrebe et al., 2016; Zaccaria et al.,
2016; Alves-Barroco et al., 2018). As further advantage, the
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transparency of the zebrafish facilitates microscopic monitoring.
Our fluorescence microscopic visualization results of zebrafish
infections demonstrate the attachment of pneumococci at
endothelial vessel walls and confirm the recruitment of
endogenous zebrafish-VWF to the surface of pneumococci
circulating in zebrafish larvae. In line with these observations, a
further most important finding is the VWF-mediated bacterial
aggregation of up to 10µm in diameter, which we only detected
in bacterial in vivo infection of alive zebrafish larvae. The
VWF-mediated bacterial aggregate formation in the zebrafish
vasculature might cause a partial or a complete occlusion of
the larval microvasculature and might contribute to vascular
dysfunction, which is known to be implicated in several different
severe cardiovascular complications. For example, some case
reports highlight the relevance of S. pneumoniae infection
as cause of uncommon but repeatedly diagnosed abdominal
infectious aortitis (Maclennan et al., 1997; Bronze et al., 1999;
Cartery et al., 2011). This diagnosis is often associated with
a high mortality rate due to non-specific disease symptoms
which result in a long diagnosis delay (Postema et al., 2011). In
addition, post-infectious vasculitis is described as complication
occurring after pneumococcal meningitis (Lucas et al., 2016),
which might also induce ischemic cerebrovascular accidents
(Khardenavis et al., 2017). According to a study based on
87 cases of pneumococcus meningitis, Kastenbauer and Pfister
calculated a rate of 21.8% arterial cerebrovascular complications
post S. pneumoniae meningitis (Kastenbauer and Pfister, 2003).
A combination of single photon emission computed tomography
(SPECT), cerebral angiography and conventional computer
tomography of 14 adults monitored abnormalities in regional
cerebral blood flow as frequent findings in patients suffering
from bacterial meningitis. These abnormalities in blood flow
might directly contribute to inflammation-mediated increase
in VWF-concentration and subsequent coagulation processes
(Förderreuther et al., 1992). Moreover, representing a life
threatening disease, CAP has been identified as an independent
risk factor for up to one third of CAP patients for the
development of major adverse cardiac events (MACE) (Musher
et al., 2007; Corrales-Medina et al., 2015; Rae et al., 2016). In this
regard, the pneumococcus-VWF interaction might contribute to
two further proposed virulence mechanisms, which are supposed
to be involved in induction of cardiovascular complications upon
pneumococcus infection. First, cardiac tissue analyses of a non-
human primate model of pneumococcal pneumonia indicated
that S. pneumoniae invades the myocardium and induces cardiac
injury with necroptosis and apoptosis (Reyes et al., 2017). This
study is linked to a former publication by Brown and colleges in
2014, which demonstrated that a direct pneumococcal invasion
of the heart is accompanied with the induction of bacteria-
filled microlesions within the myocardium, thereby inducing
cardiomyocyte death and disruption of cardiac contractility
(Brown et al., 2014). Second, Alhamdi and colleges reported
a contribution of pneumolysin-induced myocardial injury to
life-threatening acute cardiac complications as measured by
elevated cardiac troponin concentrations (Alhamdi et al., 2015).
The impact of pneumolysin on myocardial damage was further
specified in mouse infection studies, which demonstrated
pneumolysin-mediated necroptosis within the cardiac tissue
following pneumococcal myocardial invasion (Gilley et al.,
2017). The findings are in line with our former studies
showing that VWF secretion of human endothelial cells is
triggered by pneumolysin (Luttge et al., 2012). In the same
study we demonstrate that attachment of pneumolysin-negative
pneumococcus strains to endothelium induces VWF secretion to
similar levels as pneumolysin-producing strains, indicating that
pneumolysin is strongly promoting but not exclusively required
to induce cardiovascular deficiencies (Luttge et al., 2012).
Evaluating our data under consideration of the published
context, we suggested that pneumococcus-derived cardiovascular
injury occurs via at least three different pathomechanisms:
(i) pneumococcal invasion of myocardial cells, (ii) cytolytic
activity of pneumolysin, and (iii) VWF-mediated cardiovascular
occlusion. These three pathomechanisms might cause the
reported cardiac injury as complication of pneumococcal
infection in synergistic manner.
In summary, our data demonstrate the recruitment of
VWF to the bacterial surface and the use of VWF-strings
as endothelial anchor sites for the cocci in blood flow.
Our data provide strong evidence that in addition to
the VWF-mediated bacterial attachment to the vascular
endothelium, this interaction induces the formation of bacterial
aggregates leading to distributed vascular occlusions. Since
vascular occlusion has been reported as a major cause for
cardiovascular diseases, our data provide a possible link
between the pneumococcus-VWF binding to the severe
cardiovascular complications described in contribution to
systemic pneumococcus infections.
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